Publikationen von Andreas H. Jacobs
Alle Typen
Zeitschriftenartikel (111)
2016
Zeitschriftenartikel
43 (10), S. 1352 - 1365 (2016)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis. European Journal of Neuroscience: European Neuroscience Association 2013
Zeitschriftenartikel
34 (1), S. 351 - 354 (2013)
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiology of Aging
Zeitschriftenartikel
40 (10), S. 1595 - 1606 (2013)
Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging 2012
Zeitschriftenartikel
11 (6), S. 516 - 527 (2012)
Volumetry of [C-11]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma. Molecular Imaging
Zeitschriftenartikel
53 (7), S. 1135 - 1145 (2012)
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. Journal of Nuclear Medicine 2011
Zeitschriftenartikel
317 (20), S. 2864 - 2873 (2011)
NUMB does not impair growth and differentiation status of experimental gliomas. Experimental Cell Research
Zeitschriftenartikel
10 (6), S. 453 - 459 (2011)
Imaging of non-or very subtle contrast-enhancing malignant gliomas with [ 11C]-methionine positron emission tomography. Molecular Imaging
Zeitschriftenartikel
10 (3), S. 197 - 205 (2011)
Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids. Molecular Imaging
Zeitschriftenartikel
13 (3), S. 276 - 285 (2011)
Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia
Zeitschriftenartikel
13 (3), S. 547 - 557 (2011)
FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas. Molecular Imaging and Biology
Zeitschriftenartikel
12 (6), S. 583 - 593 (2011)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet-Oncology
Zeitschriftenartikel
84 (Spec. Iss. 2), S. S168 - S178 (2011)
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: Pre-clinical developments. British Journal of Radiology
Zeitschriftenartikel
84 (Spec. Iss. 2), S. S179 - S195 (2011)
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. British Journal of Radiology
Zeitschriftenartikel
29 (13), S. 1701 - 1708 (2011)
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. Journal of Clinical Oncology 2010
Zeitschriftenartikel
9 (9), S. 906 - 920 (2010)
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurology
Zeitschriftenartikel
96 (2), S. 231 - 239 (2010)
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology
Zeitschriftenartikel
9 (1), S. 40 - 46 (2010)
Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Molecular Imaging
Zeitschriftenartikel
1802 (10), S. 819 - 839 (2010)
Mouse models in neurological disorders: Applications of non-invasive imaging. Biochimica et Biophysica Acta - Molecular Basis of Disease 2009
Zeitschriftenartikel
50 (12), S. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine
Zeitschriftenartikel
17 (8), S. 1311 - 1312 (2009)
Rapid tumor cell swelling and bursting: beware of collateral damage- Response. Molecular Therapy